Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CNY 9,176.269 million compared to CNY 7,751.139 million a year ago. Operating income was CNY 684.329 million compared to CNY 507.418 million a year ago. Net income was CNY 521.069 million compared to CNY 422.714 million a year ago. Basic earnings per share from continuing operations was CNY 0.9177 compared to CNY 0.812 a year ago.